Sinopharm
1099.HK
#2137
Rank
S$9.23 B
Marketcap
$2.96
Share price
-2.02%
Change (1 day)
-18.56%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.52

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.52. In 2022 the company made an earnings per share (EPS) of $0.52 an increase over its 2021 EPS that were of $0.51.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.521.3%
2021$0.5110.33%
2020$0.4617.26%
2019$0.405.44%
2018$0.38-0.87%
2017$0.3819.44%
2016$0.3215.3%
2015$0.2817.06%
2014$0.2421.9%
2013$0.1911.82%
2012$0.1725.24%
2011$0.1431.02%
2010$0.113.3%
2009$0.1046.85%
2008$0.0692967.57%
2007$0.04135310.24%
2006$0.01008